Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin D2 (PGD2) is a bioactive lipid compound belonging to the prostaglandin family, derived from arachidonic acid. It is primarily produced by mast cells and plays significant roles in inflammation, allergic responses, neuromodulation, and sleep regulation. PGD2 exerts its effects mainly through two G protein-coupled receptors, PTGDR (DP1) and CRTH2 (DP2).
Inhibition of cyclooxygenases (COX-1, COX-2) leading to decreased PGD2 synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin D2 (PGD2).